Environmental, Social And Governance Report

Overview

The report presents the Group's 2025 environmental, social and governance policies, measures and performance across its pharmaceutical and finance leasing businesses. It assigns overall responsibility for ESG strategies and reporting to the Board and describes an ESG working team operating under Board supervision. The report discloses Group-wide greenhouse gas, energy, water and waste metrics for 2025. It also reports that climate scenario analysis commenced in 2025, covering physical and transition risks using SSP and NGFS scenarios.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English, Chinese
Pages
File size

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services